ASHM offers a range of face-to-face, webinar and online training courses specifically designed for health professionals and any other specific workforces that require hepatitis C education and training.
ASHM tailors training courses to address the specific needs of the audience and epidemiology and service practicalities of the locality in which it is delivered. We use local experts to deliver the training wherever possible.
We can develop and tailor courses to meet your specific needs. Please contact ASHM if you would like to discuss customised training for your workforce.
A comprehensive education program for medical practitioners wishing to prescribe HCV treatment independently. The program includes a predisposing case study activity, online learning module, full day face-face workshop and reinforcing activity. Through case study discussions, the interactive workshop covers diagnosis and assessment, treatment decisions, monitoring during and post-treatment, and special issues such as; resistance, treating HCV in renal patients, HIV-HCV co-infection, HBV reactivation and risk of HCC during /after DAA therapy for HCV.
Duration: 2.5 hour online learning Module (Curing Hepatitis C in Primary Care – eLearning) + 5 hour face-face workshop
CPD: Active Learning Module: 40 Category 1 RACGP QI & CPD points.
A comprehensive education program for practitioners working in drug and alcohol settings or with people who inject drugs. The program is designed to provide participants with the confidence and clinical decision-making skills to be able to increase testing and linkage to HCV care in their practice, and to prescribe DAA therapy either independently or in consultation with a specialist.
The program includes an online learning module and highly interactive workshop enabling practical and collaborative application of knowledge through case study discussions.
To enable course participants to demonstrate their competency in management and treatment of hepatitis C.
Course participants, who successfully complete all components of this course including the online assessment, will have the confidence, knowledge and clinical decision-making skills to be able to prescribe DAAs for the treatment of HCV infection, either independently or in collaboration with a specialist as appropriate to enable course participants to demonstrate their competency in management and treatment of hepatitis C.
Duration: 2.5 hour online learning module (Hepatitis C in Primary Care and Drug and Alcohol Settings Education Program – eLearning) + 6 hour face-face workshop
CPD: Active Learning Module: 40 Category 1 RACGP QI & CPD points
An introductory course for GPS, nurses and other primary care based practitioners covering; HCV epidemiology, identifying priority populations for testing, interpreting test results and diagnosis, pre-treatment assessment, evaluating liver fibrosis, treatment for hepatitis C, mechanisms for prescribing (either independently or in consultation with a specialist), monitoring and follow-up.
Duration: 2.5 hours face-face workshop
CPD: 4 Category 2 RACGP QI & CPD point.
An introductory course for practitioners working drug and alcohol settings or with people who inject drugs covering epidemiology, testing and diagnosis, fibrosis assessment and treatment of hepatitis C according to recommended guidelines. The course is open to all AOD staff including; GPs, addictions specialists, nurses and allied health.
Duration: 2.5 hours face-face workshop
CPD: 4 Category 2 RACGP QI & CPD points
This 2 day face to face course is designed for nurses working in Primary Health Care settings including General Practice, Corrective Services, Drug and Alcohol services, mental health services. The program content is delivered through presentations and case discussions that introduce the epidemiology and natural history of hepatitis C, population groups to consider for screening, testing and the nurses role in case finding, assessment for treatment, fibrosis assessment, advanced liver disease, stigma and discrimination.
Duration: 2 days face-face workshop
CPD: 13 hours CPD (APNA and ACN endorsed activity) Certificate of attendance provided .
This online learning module consists of 4 individual modules covering; HCV epidemiology, prevention and natural history; HCV testing and liver disease staging; Treatment options for HCV; and Monitoring, adherence and post-treatment follow-up. These modules are designed for medical practitioners working in drug and alcohol settings or with people who inject drugs.
Duration: 2 hours
Part 1 of this online learning consists of 4 individual modules covering; HCV epidemiology, prevention and natural history; HCV testing and liver disease staging; Treatment options for HCV; and Monitoring, adherence and post-treatment follow-up. These modules are designed for medical practitioners, nurses and other health care professionals working in primary care settings.
Duration: 2.5 hours
Part 2 of the eLearning is a case-based Refresher Module that aims to reinforce the assessment, management, treatment selection and monitoring for people with chronic hepatitis C.
Duration: 30 mins
Developed by AIVL, the ‘Normal Day’ podcast series and resources features conversations between healthcare professionals and people who use drugs on the challenges and misunderstandings that sometimes occur within the clinical relationship. The six-part series includes interviews with GPs, pharmacists, researchers, emergency room physicians and GP receptionists who provide unique insights and rarely heard perspectives.
Duration: 1.5 hours
ASHM is experienced in the delivery of webinars and provides opportunities for health professionals to access ASHM and partner organisation training remotely. Existing webinars cover clinical skill development, health promotion and research dissemination. Participants can register and ‘attend’ online to enable them to interact with presenters or can access recordings at any time for convenience.
Find a webinar happening soon or access a webinar recording.